Bone Morphogenetic Protein 6 Inhibits the Immunomodulatory Property of BMMSCs via Id1 in Sjögren's Syndrome

Mesenchymal stem cells (MSCs) treatment has emerged as a promising approach for treating Sjögren's syndrome (SS). Impaired immunoregulatory activities of bone marrow mesenchymal stem cells (BMMSCs) are found in both SS patients and animal models, and the underlying mechanism is poorly understoo...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yingying, Gu, Yi, Wu, Ruiqing, Wang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098892/
https://www.ncbi.nlm.nih.gov/pubmed/30174696
http://dx.doi.org/10.1155/2018/9837035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098892/
https://www.ncbi.nlm.nih.gov/pubmed/30174696
http://dx.doi.org/10.1155/2018/9837035

Ejemplares similares